Sixth Street Partners Management Company »

Arrivent Biopharma shares owned by Sixth Street Partners Management Company

Quarter-by-quarter ownership of Arrivent Biopharma (AVBP) shares owned by Sixth Street Partners Management Company from 13F filings

Historical chart of Sixth Street Partners Management Company investment in Arrivent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arrivent Biopharma held by Sixth Street Partners Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrivent Biopharma by Sixth Street Partners Management Company

Quarter filed Position value Share count Share price at filing
2026-06-30 $10M 294k 34.74

More positions owned by Sixth Street Partners Management Company

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Schwab Strategic Tr Fundamental Us L (FNDX)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
UnitedHealth (UNH)
Tesla Motors (TSLA)
Micron Technology (MU)
Schwab Strategic Tr Fundamental Intl (FNDF)
Eli Lilly & Co. (LLY)
Home Depot (HD)

View all positions for Sixth Street Partners Management Company

Top funds holding Arrivent Biopharma

Suvretta Capital Management
Infinitum Asset Management
Hillhouse Capital Advisors
BlackRock
OrbiMed Advisors
FMR
Octagon Capital Advisors
Vanguard Capital Management
Sofinnova Ventures
Vivo Capital
Novo A/S
General Catalyst Group Management
State Street Corporation
Logos Global Management
Geode Capital Management

View all funds holding Arrivent Biopharma